Budesonide EP Impurity E

Product Description
CAT No.
ALN-B022006
CAS No.
131918-64-4
Mol. F.
C25H32O6
Mol. Wt.
428.5
Stock
Please Inquire
Product Overview
Technical Data
Reference
RFQ
Product Overview
Chemical Name : 16α,17-[(1RS)-Butylidenebis(oxy)]-11β,21-dihydroxypregna-1,4,14-triene-3,20-dione (as per EP);
16α,17-[Butylidenebis(oxy)]-11β,21-dihydroxypregna-1,4,14-triene-3,20-dione (as per USP)
Smiles : C[C@@]12[C@@]3(C(CO)=O)[C@@](OC(O3)CCC)([H])C=C1[C@]4([H])CCC5=CC(C=C[C@]5(C)[C@@]4([H])[C@@H](O)C2)=O
Synonym : Budesonide USP Related Compound E ; 14,15-Dehydrobudesonide (USP)
Technical Data
Reference
A validated stability indicating UHPLC method for the determination of anti-inflammatory corticosteroid budesonide epimers
By Vaddi, Lakshmi; Purushothaman, Vijayanthimala; Gowda, NagarajnFrom Journal of Pharmaceutical Sciences and Research (2020), 12(6), 848-852
Analytical method development and validation of formoterol fumarate and budesonide in pressurized meter dose inhaler form by using RP-HPLC
By Raghu, P. S. – From European Journal of Biomedical and Pharmaceutical Sciences (2018), 5(6), 1-6
Isolation and characterization of photodegradation impurity in budesonide drug product using LC-MS and NMR spectroscopy
By Bhutnar, Arun; Khapare, Sachin; Desai, Anita; Dsouza, Smitha – From American Journal of Analytical Chemistry (2017), 8(7), 449-461
RFQ